These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33625074)

  • 1. Core outcome set for pediatric chronic pain clinical trials: results from a Delphi poll and consensus meeting.
    Palermo TM; Walco GA; Paladhi UR; Birnie KA; Crombez G; de la Vega R; Eccleston C; Kashikar-Zuck S; Stone AL
    Pain; 2021 Oct; 162(10):2539-2547. PubMed ID: 33625074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated recommendations on measures for clinical trials in pediatric chronic pain: a multiphase approach from the Core Outcomes in Pediatric Persistent Pain (Core-OPPP) Workgroup.
    Palermo TM; Li R; Birnie KA; Crombez G; Eccleston C; Kashikar-Zuck S; Stone AL; Walco GA
    Pain; 2024 May; 165(5):1086-1100. PubMed ID: 38112633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.
    Callis Duffin K; Merola JF; Christensen R; Latella J; Garg A; Gottlieb AB; Armstrong AW
    JAMA Dermatol; 2018 Oct; 154(10):1137-1144. PubMed ID: 29874367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.
    Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Rubin AT; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT;
    Br J Dermatol; 2022 Nov; 187(5):730-742. PubMed ID: 35762296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core outcome domains for clinical trials in non-specific low back pain.
    Chiarotto A; Deyo RA; Terwee CB; Boers M; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Lin CW; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Eur Spine J; 2015 Jun; 24(6):1127-42. PubMed ID: 25841358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Core Rehabilitation Outcome Set for Single-Sided Deafness (CROSSSD) study: International consensus on outcome measures for trials of interventions for adults with single-sided deafness.
    Katiri R; Hall DA; Hoare DJ; Fackrell K; Horobin A; Hogan N; Buggy N; Van de Heyning PH; Firszt JB; Bruce IA; Kitterick PT;
    Trials; 2022 Sep; 23(1):764. PubMed ID: 36076299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
    Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Trials; 2014 Dec; 15():511. PubMed ID: 25540987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
    Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
    Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core Outcome Set for Actinic Keratosis Clinical Trials.
    Reynolds KA; Schlessinger DI; Vasic J; Iyengar S; Qaseem Y; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood C; Kim JYS; Lee EH; Lissner GS; Marghoob AA; Matin RN; Mattox A; Mittal BB; Thomas JR; Zhou XA; Zloty D; Schmitt J; Kirkham J; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
    JAMA Dermatol; 2020 Mar; 156(3):326-333. PubMed ID: 31939999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international Delphi consensus process to determine a common data element and core outcome set for frailty: FOCUS (The Frailty Outcomes Consensus Project).
    Prorok JC; Williamson PR; Shea B; Rolfson D; Mañas LR; Cesari M; Kim P; Muscedere J
    BMC Geriatr; 2022 Apr; 22(1):284. PubMed ID: 35382752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevant domains, core outcome sets and measurements for implant dentistry clinical trials: The Implant Dentistry Core Outcome Set and Measurement (ID-COSM) international consensus report.
    Tonetti MS; Sanz M; Avila-Ortiz G; Berglundh T; Cairo F; Derks J; Figuero E; Graziani F; Guerra F; Heitz-Mayfield L; Jung RE; Lai H; Needleman I; Papapanou PN; Sailer I; Sanz-Sanchez I; Schwarz F; Shi J; Thoma D
    Clin Oral Implants Res; 2023 May; 34 Suppl 25():4-21. PubMed ID: 37232121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.
    Lang KM; Harrison KL; Williamson PR; Huntly BJP; Ossenkoppele G; Geissler J; Bereczky T; Hernández-Rivas JM; Chevrou-Séverac H; Goodbody R; Schulze-Rath R; Bullinger L
    Trials; 2020 May; 21(1):437. PubMed ID: 32460828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Core Outcome Set for Pediatric Critical Care.
    Fink EL; Maddux AB; Pinto N; Sorenson S; Notterman D; Dean JM; Carcillo JA; Berg RA; Zuppa A; Pollack MM; Meert KL; Hall MW; Sapru A; McQuillen PS; Mourani PM; Wessel D; Amey D; Argent A; Brunow de Carvalho W; Butt W; Choong K; Curley MAQ; Del Pilar Arias Lopez M; Demirkol D; Grosskreuz R; Houtrow AJ; Knoester H; Lee JH; Long D; Manning JC; Morrow B; Sankar J; Slomine BS; Smith M; Olson LM; Watson RS;
    Crit Care Med; 2020 Dec; 48(12):1819-1828. PubMed ID: 33048905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core outcomes for pressure ulcer prevention trials: results of an international consensus study: Classification: Outcomes and qualitative research.
    Lechner A; Coleman S; Balzer K; Kirkham JJ; Muir D; Nixon J; Kottner J
    Br J Dermatol; 2022 Nov; 187(5):743-752. PubMed ID: 35789479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Preliminary Core Domain Set for Clinical Trials of Shoulder Disorders: A Report from the OMERACT 2016 Shoulder Core Outcome Set Special Interest Group.
    Buchbinder R; Page MJ; Huang H; Verhagen AP; Beaton D; Kopkow C; Lenza M; Jain NB; Richards B; Richards P; Voshaar M; van der Windt D; Gagnier JJ;
    J Rheumatol; 2017 Dec; 44(12):1880-1883. PubMed ID: 28089972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
    Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop.
    Morgan EM; Munro JE; Horonjeff J; Horgan B; Shea B; Feldman BM; Clairman H; Bingham CO; Thornhill S; Strand V; Alongi A; Magni-Manzoni S; van Rossum MAJ; Vesely R; Vojinovic J; Brunner HI; Harris JG; Horton DB; Lovell DJ; Mannion M; Rahimi H; Ravelli A; Ringold S; Ruperto N; Schrandt MS; Shenoi S; Shiff NJ; Toupin-April K; Tzaribachev N; Weiss P; Consolaro A
    J Rheumatol; 2019 Aug; 46(8):1006-1013. PubMed ID: 30770499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations.
    McGrath PJ; Walco GA; Turk DC; Dworkin RH; Brown MT; Davidson K; Eccleston C; Finley GA; Goldschneider K; Haverkos L; Hertz SH; Ljungman G; Palermo T; Rappaport BA; Rhodes T; Schechter N; Scott J; Sethna N; Svensson OK; Stinson J; von Baeyer CL; Walker L; Weisman S; White RE; Zajicek A; Zeltzer L;
    J Pain; 2008 Sep; 9(9):771-83. PubMed ID: 18562251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core Outcome Domains for early phase clinical trials of sound-, psychology-, and pharmacology-based interventions to manage chronic subjective tinnitus in adults: the COMIT'ID study protocol for using a Delphi process and face-to-face meetings to establish consensus.
    Fackrell K; Smith H; Colley V; Thacker B; Horobin A; Haider HF; Londero A; Mazurek B; Hall DA
    Trials; 2017 Aug; 18(1):388. PubMed ID: 28835261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.